Example of conditiondefinition

{
  "resourceType": "ConditionDefinition",
  "id": "example",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition &quot;example&quot; </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id: urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#24331-1 &quot;Lipid 1996 panel - Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35200-5 &quot;Cholesterol [Moles/​volume] in Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35217-9 &quot;Triglyceride [Moles/​volume] in Serum or Plasma&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2085-9 &quot;HDL Cholesterol&quot;)</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#13457-7 &quot;Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation&quot;)</span></p></blockquote><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"broken-link.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>"
  },
  "url": "http://hl7.org/fhir/ConditionDefinition/example",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.25.1"
    }
  ],
  "name": "Hyperlipidemia",
  "title": "Hyperlipidemia Status",
  "status": "draft",
  "date": "2019-05-26T10:44:00+10:00",
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "55822004",
        "display": "Hyperlipidemia (disorder)"
      }
    ]
  },
  "hasSeverity": false,
  "hasBodySite": false,
  "hasStage": false,
  "definition": [
    "https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"
  ],
  "observation": [
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24331-1",
            "display": "Lipid 1996 panel - Serum or Plasma"
          }
        ],
        "text": "Lipid Panel"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "35200-5",
            "display": "Cholesterol [Moles/​volume] in Serum or Plasma"
          }
        ],
        "text": "Cholesterol"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "35217-9",
            "display": "Triglyceride [Moles/​volume] in Serum or Plasma"
          }
        ],
        "text": "Triglyceride"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "HDL Cholesterol"
          }
        ],
        "text": "Cholesterol in HDL"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"
          }
        ],
        "text": "LDL Chol. (Calc)"
      }
    }
  ],
  "medication": [
    {
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "203151",
            "display": "Gemfibrozil"
          }
        ]
      }
    }
  ],
  "plan": [
    {
      "reference": {
        "reference": "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"
      }
    }
  ]
}